As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
PAMs inhibits monoamine oxidase a activity and reduces glioma tumor growth, a potential adjuvant treatment for glioma
Natural plant antimicrobial solution alone or co-administration with low doses of temozolomide may be a potential adjuvant to reduce the toxicity of temozolomide and to evade drug resistance for the effective treatment of glioma.
In this review one of our Section Editors, Jacobus Eloff, provides advice for researchers who wish to investigate the antimicrobial properties of plant derived extracts.
BMC Series Focus Issues
In preparation for Earth Day on 22nd April, the BMC Series presents a focus issue on Our Changing Environment, highlighting research from across the journals on climate change, conservation, pollution, and the impact of environmental changes on human health and disease.
With the 28th of February marking World Rare Diseases day, the BMC Series this month looks at highlighting research on the Rare diseases that together affect around 10% of the population. Read the full collection of articles here.
BMC Complementary Medicine and Therapies – we’ve updated our Research Standards
We are pleased to announce the new Research Standards for manuscripts submitted to BMC Complementary Medicine and Therapies. These changes renew the journal’s commitment to providing objective evidence for the efficacy or utilisation of complementary and alternative therapies. We will consider all manuscripts which meet these criteria. Click the button below to read more.Read More
Aims and scope
BMC Complementary Medicine and Therapies is an open access journal publishing original peer-reviewed research articles on interventions and resources that complement or replace conventional therapies, with a specific emphasis on research that explores the biological mechanisms of action, as well as their efficacy, safety, costs, patterns of use and/or implementation.
About to Submit a Systematic Review?
BMC Complementary Medicine and Therapies is affiliated with Cochrane Complementary Medicine. The purpose of this affiliation is to improve the standard of Systematic Review reporting at the journal. Click the link below for an Editorial with more information on this partnership and how the journal treats Systematic Reviews.Read More
Anne Menard, BioMed Central
Esther Fagelson, BioMed Central
Kate Gaines, BioMed Central
Senior Editorial Board Members
Victor Kuete, University of Dschang
Jianping Liu, Beijing University of Chinese Medicine
Insop Shim, Kyung Hee University
Jenny Wilkinson, Charles Sturt University
Amie Steel, University of Technology Sydney
I am currently a professor at College of Medicine, Kyung Hee University. I hold a Ph.D. in Biopsychology (Behavioral Neuroscience) from University of Illinois at Chicago and completed my post-doctoral fellowship at the Department of Psychiatry, School of Medicine University of Illinois. I am a member of the Society for Neuroscience and have served as an organizing committee of many International conferences and served as the Editor-in-Chief of Korean Society of Stress Medicine and Executive Editor of Experimental Neurobiology.
My research expertise is in the areas of neural mechanisms responsible for motivational behaviors including stress, drugs of abuse, and learning and memory. It is the goal of my research in particular, to elucidate both the effects and the mechanisms of action of the herbal medicine or complementary and alternative medicine (CAM) using animal models of stress-related diseases such as anxiety, depression, insomnia or learning and memory. I have joined a board member since Aug, 2016.
BMC Series Blog
Annual Journal Metrics
83 days to first decision for reviewed manuscripts only
39 days to first decision for all manuscripts
217 days from submission to acceptance
23 days from acceptance to publication
For BMC Complementary and Alternative Medicine (former title)
2.833 - 2-year Impact Factor
2.986 - 5-year Impact Factor
1.326 - Source Normalized Impact per Paper (SNIP)
0.741 - SCImago Journal Rank (SJR)